Kantemir K. Dzamikhov

Kantemir K. Dzamikhov

Auto-generated profile, based on publicly available information

Kantemir K. Dzamikhov

Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OOO. D. Ostroumova
O. D. Ostroumova
TOT. M. Ostroumova
T. M. Ostroumova
KDK. K. Dzamikhov
K. K. Dzamikhov
Arterial hypertension is one of the main modifiable risk factor for cognitive impairement (CI). Most frequently executive dysfunction is seen independent of age. Pathophysiological mechanisms linking hypertension and CI include the impact of increased blood pressure on large and small cerebral arteries. Large arteries dysfunction leads to occlusion, remodeling and arterial stiffness. Hypertension also causes small arteries dysfunction: lipohyalinosis and fibrinoid necrosis and due to insufficient amount of anastomosis and collaterals can lead to white matter damage. Treatment approach for patients with hypertension and CI should be multimodal and include treatment of the main cause of CI (antihypertensive therapy, statins and antithrombotics if necessary), symptomatic therapy (e.g. anti-dementia medications) and pathogenic treatment drugs that influence microcirculation, neuromethabolic therapy. Antihypertensive therapy is known to decrease dementia incidence, but the interclass differences remain unclear. Nicergoline (the ergot alkaloid derivative) is used in 30 countries to treat CI. Nicergoline improves CI due to its multidoi modal action, which includes increasing glucose metabolism in the brain, stimulation of cholinergic neurotransmission, increasing cerebral blood flow, influencing microcirculation due to decreasing arterial stiffness, blocking α1-adrenergic receptors. Nicergoline is effective in treating hypertensive patients with CI according to the data of a number of studies and meta-analysis. Evidencebased data also shows good tolerance profile of nicergoline.

1 January 2020 in Siberian Medical Review
Verified
Journal Article
Closed access
RERussian Medical Academy Of Postgraduate Education
Russian Medical Academy Of Postgraduate Education
OOO.D. Ostroumova
O.D. Ostroumova
MKM.V. Klepikova
M.V. Klepikova
KDK.K. Dzamikhov
K.K. Dzamikhov
VDV.A. De
V.A. De
SLS.N. Litvinova
S.N. Litvinova
Nowadays, there is an increasing necessity to use a lot of medical products (MP) in one patient. This can lead to potential nephrotoxic adverse reactions (ADRs) among drugs. One of drug-induced kidney damage manifestations is acute tubular necrosis (ATN), which causes the development of severe complications associated with the use of hemodialysis and a high risk of mortality. The purpose of this review is to analyze literature data concerning groups of drugs and individual drugs, the intake of which is associated with the development of drug-induced ATN, risk factors, prevention and treatment methods. Among drug-induced ATN development risk factors are both general, associated with the development of drug-induced acute kidney damage (for example, age, history of chronic kidney disease, etc.), and specific ones, typical for certain groups of drugs. Most often, drug-induced ATN develops while taking antibacterial, antiviral and anticancer drugs. The main method of treatment for drug-induced ATN is abolition of nephrotoxic drugs, but if it is impossible, then there are certain patient management schemes. To prevent and to diagnose drug-induced ATN at early stages, that is the key for favorable prognosis, it is necessary to aware of doctors of different specialties about such pharmacotherapy complications.

13 May 2025 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Open access
PDF file
KDKantemir K. Dzamikhov
Kantemir K. Dzamikhov
AKAleksey I. Kochetkov
Aleksey I. Kochetkov
OOOlga D. Ostroumova
Olga D. Ostroumova
VSVera R. Shastina
Vera R. Shastina
AAAlexander V. Arablinskiy
Alexander V. Arablinskiy
АВАраблинский Александр Владимирович
Араблинский Александр Владимирович
BACKGROUND: Increasing life expectancy is closely related to the increasing burden of polymorbidity, as well as the number of medications per patient of elderly and senile age (polypharmacy). These factors can have a direct and indirect impact on the cognitive and functional status of patients, which is of utmost importance for preserving both, the duration and the quality of life of older patients. AIM: Assessment of functional status of multimorbid elderly patients with essential arterial hypertension depending on the burden and structure of multimorbidity and its possible relationship with cognitive function condition. METHODS: 330 patients aged ≥ 60 years with arterial hypertension (median age 79 years, 50.6% women) were included in the study. All patients underwent assessment of functional status using the Functional Activities Questionnaire (FAQ) and cognitive functions using the Montreal Cognitive Assessment Scale, Mini-Mental State Examination, Alzheimer’s Disease Assessment Scale (Cognitive Subscale). RESULTS: The median total score on the FAQ questionnaire was statistically significantly higher in the atrial fibrillation group [12 (9–14) points] compared to the arterial hypertension group without atrial fibrillation [10 (6–12) points; p = 0.001], in the chronic kidney disease group [11 (8–14) points] than in the group without chronic kidney disease [10 (6–13) points; p = 0.002). The median final FAQ questionnaire score was statistically significantly (p 0.001) higher in the group of patients with a Charlson comorbidity index ≥ 8 points [12 (9–15) points] compared to that in the group of patients with a Charlson index score of 0–4 points [9 (6–11) points]. According to linear regression analysis, there was a statistically significant relationship between the number of FAQ scores, on the one hand, and the patients’ age (R2 = 0.175; β = 0.422), Charlson comorbidity index (R2 = 0.044; β = 0.216), and the results of cognitive functions testing [Mini-Mental State Examination (R2 = 0.348; β = −0.591), Montreal Cognitive Assessment Scale (R2 = 0.286; β = −0.537), Alzheimer’s Disease Assessment Scale (Cognitive Subscale; R2 = 0.345; β = 0.589; p 0.001 in all cases). CONCLUSION: In elderly patients with essential arterial hypertension, the presence of concomitant atrial fibrillation and chronic kidney disease has a negative impact on their functional activity and cognitive status. Decrease in functional activity and deterioration of cognitive functioning of elderly patients with arterial hypertension is also associated with increasing age and burden of multimorbidity (Charlson index).

19 January 2024 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
NSNatalia Shatalova
Natalia Shatalova
KDK. K. Dzamikhov
K. K. Dzamikhov
AKA. I. Kochetkov
A. I. Kochetkov
SBS. V. Batyukina
S. V. Batyukina
EEE. Y. Ebzeyeva
E. Y. Ebzeyeva
OOO. D. Ostroumova
O. D. Ostroumova
Background. Cognitive impairment is a public health problem. Polymorbid patients with arterial hypertension (AH), atrial fibrillation (AF), and chronic kidney disease (CKD) are at high risk of developing cognitive impairment, resulting in impaired quality of life, difficulty in medication adherence, and increased risk of mortality.Objective. To evaluate the cognitive status of polymorbid patients aged 60 years and older with essential AH and FP depending on the presence and stage of CKD.Materials and methods. 165 patients aged 60 years and older with essential AH and AF (80 [48.5 %] men, 85 [51.5 %] women, mean age was 82 [76; 85] years) were included and divided into three groups depending on the presence and stage of CKD: 55 (33.3 %) patients with AH and AF without CKD, 55 (33.3 %) patients with AH, AF, and CKD C 3a, and 55 (33.3 %) patients with AH, AF, and CKD C 3b. All patients included in the present study were examined for cognitive functions using a series of neuropsychological tests.Results. In the study of cognitive functions (Mini-mental State Examination, MMSE, Alzheimer Disease Assessment Scale-Cognitive (ADAS-cog), Digit Symbol Substitution Test (DSST), literature Association Test), it was found that the severity of cognitive impairment increased with increasing stage of CKD.Conclusions. The obtained results of the study indicate an unfavorable effect of CKD on cognitive functions in elderly and elderly patients with AH and FP. Thus, there is a need for regular monitoring and examination of patients with concomitant CKD for cognitive impairment.

14 May 2024 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
OOO. D. Ostroumova
O. D. Ostroumova
KDK. K. Dzamikhov
K. K. Dzamikhov
AKA. I. Kochetkov
A. I. Kochetkov
ТOТ. M. Ostroumova
Т. M. Ostroumova
EEE. Yu. Ebzeyeva
E. Yu. Ebzeyeva
VDV. B. Dashabylova
V. B. Dashabylova
The aim of the study was to evaluate the effect of anticholinergic load (AHN) on cognitive functions (CF) in elderly and senile multimorbid patients with arterial hypertension (AH).Materials and methods. 330 patients aged 60 years and older with essential AH were included in the study (median age 79 [72; 84] years, 158 (51 %) of women). All the patients were underwent the assesment of CF using the Montreal Cognitive Assessment Scale (MoCA), Mini-Mental Status Scale (MMS), Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-cog), Trial Making Test (TMT), Digit Symbol Substitution Test (DSST), Verbal Association Test (literal (letter) and categorical (animal) associations), Boston Naming Test (BNT), Word-Color Interference Test, Stroop colorword conflict test. The anticholinergic load was determined using the anticholinergic load scale (Anticholinergic Cognitive Burden Scale, ACB).Results. Compared with patients who do not take anticholinergic drugs, multimorbid elderly and senile hypertensive patients with 2 or more points on the ACB scale had significantly lower final scores on the MoCA test (23 [21; 24.3] versus 24 [22; 25] points, respectively, p=0.042) and on MMSE (26 [24; 29] vs. 27.5 [25; 29] points, respectively, p=0.015), they spent statistically more time completing part B of the TMT test (217.5 [187.3; 246.3] vs. 204 [166.8; 247.3] seconds, respectively, p=0.038). The difference between the execution time of part B and part A of the TMT test in patients with 2 or more points on the ACB scale was statistically significantly greater than in patients with 0 points on this scale (141 [103.8; 168.5] versus 124 [83.8; 162] sec, respectively, p=0.034). Age, gender, education, and the structure of concomitant diseases did not differ between the groups.Conclusion. The results obtained indicate the adverse effect of аnticholinergic вurden on CF of multimorbid elderly and senile hypertensive patients and dictate the need to optimize pharmacotherapy in this category of patients.

1 January 2024 in Nephrology and Dialysis
Verified
Journal Article
Closed access
RERussian Medical Academy Of Continuous Professional Education
Russian Medical Academy Of Continuous Professional Education
OOO.D. Ostroumova
O.D. Ostroumova
SUSechenov First Moscow Medical University (Sechenov University)
Sechenov First Moscow Medical University (Sechenov University)
KDK.K. Dzamikhov
K.K. Dzamikhov
AKA.I. Kochetkov
A.I. Kochetkov
VDV.B. Dashabylova
V.B. Dashabylova